PTGX Protagonist Therapeutics Inc.
Health Care, filed as PROTAGONIST THERAPEUTICS INC (COM), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab
In 2026 Q3 Polen Capital Management trimmed Protagonist Therapeutics, and Stanley Druckenmiller sold out.
Who owns this now
Largest portfolio weights among holders, up to 3.9% (Farallon Capital Management). Not free-float ownership.
Who owns PTGX
Sorted by value, long equity only, as of 2026 Q3. Exits show their last held size.
| History | |||||
|---|---|---|---|---|---|
| Farallon Capital Management | Small add +1.4% | 6,437,906 | $907M | History | |
| James Silverman, Opaleye Management | Hold | 100,000 | $14M | History | |
| Polen Capital Management | Reduce −7.5% | 20,963 | $3M | History | |
| Ron Baron, BAMCO Inc. (Baron Capital) | Hold | 16,000 | $2.3M | History | |
| Stanley Druckenmiller, Duquesne Family Office exited 2026 Q3 Last 2026 Q2 | Exit −0.49% | 208,900 | $26M | History |
Insider trades
Open-market buys and sales by PTGX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $31.1M sold by 7 insiders outside a trading plan
- $51.9M sold by 3 insiders under 10b5-1 plans
-
Asif Ali CFOPlanned sale$8.3M 58,629 shares at $141.78 50% of stakeTraded Sep 30 Filed Oct 2
-
Dinesh V. Ph D. Patel CEOPlanned sale$18.2M 125,000 shares at $145.92 19% of stakeTraded Sep 8–10 Filed Sep 10
-
Dinesh V. Ph D. Patel CEOPlanned sale$14.9M 100,000 shares at $148.91 16% of stakeTraded Aug 10–11 Filed Aug 12
-
William D. Waddill DirectorPlanned sale$1.1M 9,000 shares at $117.94 54% of stakeTraded Jun 23 Filed Jun 25
-
William D. Waddill DirectorPlanned sale$969K 9,000 shares at $107.68 54% of stakeTraded Jun 10 Filed Jun 11
-
William D. Waddill DirectorPlanned sale$897K 9,000 shares at $99.64 54% of stakeTraded May 29 Filed Jun 1
-
Dinesh V. Ph D. Patel CEOPlanned sale$7.5M 75,000 shares at $100.12 13% of stakeTraded May 12 Filed May 14
-
Bryan Giraudo DirectorSale$5.9M 59,130 shares at $100.10Traded May 7–8 Filed May 11
-
Arturo Molina MD Chief Medical OfficerSale$1.6M 15,000 shares at $104.79 15% of stakeTraded Mar 26 Filed Mar 27
-
Harold E. Selick DirectorSale$2.5M 24,000 shares at $105.00 28% of stakeTraded Mar 26 Filed Mar 27
-
Asif Ali CFOSale$2.6M 24,765 shares at $104.24 29% of stakeTraded Mar 26 Filed Mar 27
-
Dinesh V. Ph D. Patel CEOSale$5.5M 54,700 shares at $101.00 9.4% of stakeTraded Mar 24–25 Filed Mar 25
-
Lewis T. Williams DirectorSale$1.5M 18,000 shares at $82.42 70% of stakeTraded Feb 17 Filed Feb 18
-
William D. Waddill DirectorSale$1.7M 20,000 shares at $83.68 72% of stakeTraded Feb 6 Filed Feb 6
-
Dinesh V. Ph D. Patel CEOSale$4.1M 48,273 shares at $84.18 7.8% of stakeTraded Jan 23–27 Filed Jan 27
Also filed in the last 12 months, not counted as buying or selling: 33 option exercises, 8 stock grants, 5 gifts, and 5 sales to cover taxes.
SEC filings
Recent issuer filings from EDGAR, 20 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| DEF 14A | FORM- DEF 14A | Filing Doc | |
| DEFA14A | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $355.58M | $591.64M | $577.57M |
| Total non-current assets * | $2.37M | $153.08M | $90.61M |
| Total assets | $357.95M | $744.72M | $668.19M |
| Total current liabilities | $21.27M | $47.4M | $45.44M |
| Total non-current liabilities * | $0M | $22.03M | $8.04M |
| Total equity | $336.68M | $675.3M | $614.71M |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon